Searched for
CONTRACT DRUG DISCOVERY
Intel spinout Articul8 eyes $50 million for India heritage AI ventureArticul8, a spin-off from Intel, is raising $30-50 million to establish an India-based AI entity focused on traditional knowledge systems l...- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- An SNL 'All Drug Olympics?' Not quite. But these Enhanced Games are no jokeThe "Enhanced Games" in Las Vegas allows athletes to use performance enhancers, aiming to challenge mainstream sports' anti-doping efforts ...
- US to invest $2 billion in IBM, other quantum computing firmsUS government will invest $2 billion in nine quantum computing firms, including IBM’s new chip venture Anderon, to strengthen America’s lea...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAs far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...
- The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garageKiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Anthem BioSciences shares jump 4% as Citi initiates with Buy rating. Check target, upside potentialShares of Anthem BioSciences rose after Citi initiated coverage with a Buy rating and a target price of ₹870, implying over 20% upside. Ana...
- Amazon launches AI research tool to speed early-stage drug discoveryAmazon Web Services has launched Amazon Bio Discovery, an AI tool to accelerate drug discovery. Scientists can now generate and evaluate po...
- US tariff a bitter pill for Indian pharmaDonald Trump's tariffs will impact Indian medicine exports. This policy targets branded and patented drugs. Indian generic drug makers face...
- CRAMS could be new wealth creators in pharma spaceMore and more pharma cos are finding it profitable to outsource all aspects from R&D to commercialisation to trusted partners in low-cost c...
- Biocon’s unit extends partnership with US-based Bristol-Myers SquibbThe two cos announced to renew their engagement, boosted by encouraging results in last 5 years, during when 6 drug molecules have been bro...
- GVK Biosciences plans Rs 100 crore active pharmaceutical ingredients facilityGVK Biosciences proposes to set up active pharmaceutical ingredients (APIs) manufacturing facility to cater to the needs of its existing an...
- GVK Biosciences, Onconova Therapeutics ink pact to develop cancer drugsThe Hyderabad-based firm and Onconova have entered into a JV to develop new drugs for cancer, GVK Biosciences said in a statement.
- Dr Reddy's in drug discovery pact with UK research firmPharma major Dr Reddy's Laboratories and Argenta, a UK-based contract research firm, have entered in to an agreement for collaboration in d...
- TCG Life signs pact with PfizerTCG group promoted TCG Life Sciences Ltd, a contract research firm in the area of drug discovery, has signed an agreement with pharma giant...
- 'Give scientists enough freedom'Researchers attached to institutions like Royal Society of the UK, Imperial College of London and various Indian universities will have an ...
- Govt to rope in young minds to invent cheaper drugsThe government has begun discussions with Sun Microsystems to set up web-management tools for an ‘open source’ drug discovery project. Day ...
- Sai Advantium to invest up to $20mSai Advantium Pharma Ltd, engaged in contract research and manufacturing, is planning to invest about $15-$20 million in stepping up produc...
- Nicholas Piramal signs agreements with UK firmIn a filing on the Bombay Stock Exchange the company said the first agreement was related to Morvus platform technology .
Load More
